Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Chief Counsel Troy Resigns; Agency Says It Will Still Support Preemption

Nov 22 2004

• By The Pink Sheet

Related Content

Antibacterial Final Rule Defers To Doctors; Labeling Will Emphasize Testing

Feb 10 2003

Generic Rx Reforms: No Automatic “Controversy” For Declaratory Judgments

Nov 24 2003

FDA Chief Counsel Is Attorney From WLF Case; Porter Leaves After 11 Years

Aug 13 2001

FDA Deputy Chief Counsel Masoudi Brings Antitrust Law Background To Post

Nov 15 2004

FDA Waxman/Hatch Policy Change Afforded Full White House Honors

Oct 28 2002

Waxman/Hatch Reinterpretation Underpins Change In 30-Month Stay Policy

Oct 28 2002

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window